1. Home
  2. IRON vs AFYA Comparison

IRON vs AFYA Comparison

Compare IRON & AFYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRON
  • AFYA
  • Stock Information
  • Founded
  • IRON 2017
  • AFYA 1999
  • Country
  • IRON United States
  • AFYA Brazil
  • Employees
  • IRON N/A
  • AFYA N/A
  • Industry
  • IRON Biotechnology: Pharmaceutical Preparations
  • AFYA Other Consumer Services
  • Sector
  • IRON Health Care
  • AFYA Real Estate
  • Exchange
  • IRON Nasdaq
  • AFYA Nasdaq
  • Market Cap
  • IRON 1.4B
  • AFYA 1.6B
  • IPO Year
  • IRON N/A
  • AFYA 2019
  • Fundamental
  • Price
  • IRON $64.03
  • AFYA $14.99
  • Analyst Decision
  • IRON Strong Buy
  • AFYA Sell
  • Analyst Count
  • IRON 10
  • AFYA 4
  • Target Price
  • IRON $73.70
  • AFYA $19.38
  • AVG Volume (30 Days)
  • IRON 253.9K
  • AFYA 111.0K
  • Earning Date
  • IRON 11-12-2024
  • AFYA 11-13-2024
  • Dividend Yield
  • IRON N/A
  • AFYA N/A
  • EPS Growth
  • IRON N/A
  • AFYA 62.61
  • EPS
  • IRON N/A
  • AFYA 1.17
  • Revenue
  • IRON N/A
  • AFYA $584,951,886.00
  • Revenue This Year
  • IRON N/A
  • AFYA $16.83
  • Revenue Next Year
  • IRON N/A
  • AFYA $11.70
  • P/E Ratio
  • IRON N/A
  • AFYA $13.10
  • Revenue Growth
  • IRON N/A
  • AFYA 16.67
  • 52 Week Low
  • IRON $25.60
  • AFYA $15.00
  • 52 Week High
  • IRON $77.60
  • AFYA $22.48
  • Technical
  • Relative Strength Index (RSI)
  • IRON 53.08
  • AFYA 32.19
  • Support Level
  • IRON $62.31
  • AFYA $15.00
  • Resistance Level
  • IRON $67.87
  • AFYA $16.21
  • Average True Range (ATR)
  • IRON 3.04
  • AFYA 0.41
  • MACD
  • IRON -0.46
  • AFYA -0.11
  • Stochastic Oscillator
  • IRON 38.78
  • AFYA 4.44

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.

About AFYA Afya Limited

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medicine, other health sciences, and other undergraduate programs, Continuing Education provides specialization programs and graduate courses in medicine; and Digital Services provides content and technology for medical education, clinical decisions software, practice management tools (that encompass electronic medical records, telemedicine, and digital prescription, and provides access, demand and efficiency for the healthcare players.

Share on Social Networks: